SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA
NCT07030075 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 594
Last updated 2025-06-19
Summary
Background and rationale:The World Health Organisation (WHO), estimates influenza global deaths at 290,000 to 650,000 annually. Although influenza is mostly associated with upper respiratory tract infections (URTIs), its role in lower respiratory tract infections (LRTIs) and the associated poor clinical outcomes have been overlooked in sub-Saharan Africa. A study conducted in eight SSA countries estimated that 8.2% of cases and 2.8% of deaths from LRTIs were due to primary infection with influenza. Pneumonia and influenza-associated illness are responsible for 8.5% of respiratory deaths in Zambia. However, in routine practice, testing to distinguish between bacterial and viral etiology of RTIs is seldom done outside sentinel surveillance due to the high cost and lack of available testing options. This consequently underestimates viral RTIs in the population. It is particularly important to diagnose flu early on in vulnerable populations so that they receive timely and appropriate medical care. Although Zambia is a high HIV burden country with a prevalence of 11%, there is presently no study that has described the burden of influenza in the HIV positive population. This research study will address gaps in current scientific knowledge, providing key insights about the prevalence, circulating types, seasonality and associated clinical outcomes of influenza, RSV and SARS-CoV-2 infection in Zambia in the post COVID-19 era.
Objectives Primary To determine the prevalence of influenza (A and/or B) infections in a high HIV burden setting in Lusaka, Zambia over one or more influenza seasons.
Secondary
1. To determine the prevalence of influenza co-infection with RSV and/or SARS-CoV-2
2. To determine the clinical outcomes of influenza (A and/or B) infection among Zambian adults, with and without co-infection with RSV and COVID-19, by HIV and COVID-19 vaccination status.
3. To evaluate the accuracy and yield of aerosol-based sampling for diagnosis of respiratory viruses (influenza, SARS-CoV-2, and RSV) compared to nasal/ nasopharyngeal swabs, for rapid diagnosis of infection among symptomatic individuals in Zambia.
4. To evaluate the acceptability of exhaled breath aerosol (XBA) sampling for diagnosis and screening of respiratory infections of pandemic potential.
Study design and participants:
Primary objective and secondary objective 1:
Cross sectional surveillance study of individuals presenting with flu-like symptoms at two first level hospitals in Lusaka, Zambia. Recruitment of 594 participants will be done over the study period and participants will include both males and females presenting with 2-7 days of flu-like symptoms, able to provide informed consent, aged ≥18 years, with a known HIV status or willing to be tested, with a known COVID 19 vaccination status and available for symptom follow-up.
Secondary objective 2:
Prospective follow up of participants enrolled in aim 1 for 14 days will be done to document clinical symptom progression and outcomes. Appropriate care will be provided to all participants within routine care services.
Secondary objective 3 \& 4:
Mixed methods approach. All patients enrolled under aim 1 will be requested to provide in addition to the routine nasopharyngeal sample, an aerosol-based sample for diagnostic accuracy and yield evaluation. We will also conduct an investigator-administered questionnaire to ascertain end-user experience and preferences for either sampling method.
Location Zambia (Kanyama and Chawama sub-districts) Duration April 2025 to November 2026 (Participant enrolment duration)
Conditions
Sponsors & Collaborators
-
Heidelberg University
collaborator OTHER -
Centre for Infectious Disease Research in Zambia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-20
- Primary Completion
- 2026-11-30
- Completion
- 2027-01-31
Countries
- Zambia
Study Locations
More Related Trials
-
Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa
NCT02439918 ·Status: COMPLETED
-
Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa
NCT04709302 ·Status: ENROLLING_BY_INVITATION
-
Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections
NCT01212042 ·Status: TERMINATED
-
Acute HIV Infection Observational Study
NCT00296660 ·Status: COMPLETED
-
Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
NCT00789009 ·Status: RECRUITING
-
Resistance in HIV+ in North and South
NCT02507921 ·Status: UNKNOWN
-
HIV Care Cascade and Linkage to Antiretroviral Therapy Among Hospitalized Adults in Lusaka, Zambia
NCT03158844 ·Status: COMPLETED
-
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570 ·Status: COMPLETED
-
Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia
NCT00807625 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of the Nasal Mucosal Immune Response in HIV Infection
NCT03920709 ·Status: UNKNOWN
-
A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infection
NCT06280001 ·Status: NOT_YET_RECRUITING
-
HIV Persistence in Lymph Node and Peripheral Blood
NCT03426189 ·Status: COMPLETED
-
Tissue Biopsy and Imaging Studies in HIV-Infected Patients
NCT00001471 ·Status: COMPLETED
-
Tfh Dysfunction in HIV and Aging
NCT04487041 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort
NCT05067400 ·Status: COMPLETED
-
HIV Accelerated Liver Disease in Uganda
NCT01524562 ·Status: COMPLETED
-
Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
NCT00006298 ·Status: COMPLETED
-
Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa
NCT00341393 ·Status: COMPLETED
-
Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population
NCT00796146 ·Status: RECRUITING
-
Infectious Diseases and Movement Program: Study of the Effects of Physical Activity on HIV Infection
NCT03392805 ·Status: UNKNOWN ·Phase: NA
-
Impact of ART Adherence on HIV Persistence and Inflammation
NCT02797093 ·Status: COMPLETED
-
Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults
NCT00776412 ·Status: COMPLETED
-
Response to Standard HIV Treatment in Bamako, Mali
NCT00703404 ·Status: COMPLETED
-
The Effects of Illnesses on HIV Levels in the Body
NCT00000900 ·Status: COMPLETED
-
Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients
NCT00001110 ·Status: COMPLETED ·Phase: NA